Status:
TERMINATED
the Implications of Pathogenesis of Pre-Eclampsia
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Preeclampsia
Eligibility:
FEMALE
20-40 years
Brief Summary
Preeclampsia is a severe complication of human pregnancy. It occurs in 4-5% of all pregnancies and remains a leading cause of maternal and neonatal mortality and morbidity. The pathophysiology of this...
Detailed Description
1. Pregnancy, pre-eclampsia and immune regulation The preeclampsia syndrome, which is characterized by changes in the placenta and uteroplacental vasculature, is a major concern in impaired human preg...
Eligibility Criteria
Inclusion
- Preeclampsia
Exclusion
- no
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00154934
Start Date
January 1 2004
End Date
January 1 2009
Last Update
February 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shih Jin-Chung
Taipei, Taiwan, 10016